Global Medical Foundation Models Market 2026 – 2035

The global Medical Foundation Models market is projected to reach USD 4.18 billion in 2026 and is expected to expand at 16.9% CAGR to USD 18.76 billion by 2035. The North America region is projected to have ~44.8% market share of the global generative AI, large language models (LLMs), multimodal AI, and cloud-based healthcare AI platform market by 2025, which is primarily fueled by the adoption rate of these AI systems by hospitals, pharmaceutical companies, biotechnology companies, research institutions, and healthcare technology providers.

It is also home to state-of-the-art healthcare technologies, investments in AI research and development, and a growing number of organisations implementing Electronic Health Records (EHRs) and leading AI solution providers, cloud service providers, and life sciences companies. The rising adoption of medical foundation models in clinical decision support, medical imaging analysis, drug discovery, clinical documentation, precision medicine and biomedical research are driving the market growth.

Furthermore, the regulatory measures pertaining to responsible utilization of AI, growing collaboration among healthcare organisations and AI technology providers, and continued investments in the digital transformation of the healthcare industry solidify North America's dominance in the Medical Foundation Models market.

Market Highlight

• Multimodal Foundation Models led the global Medical Foundation Models market in 2025 owing to their ability to integrate and process complex clinical information such as clinical text, medical images, pathology slides, genomic data, laboratory reports, and electronic health records (EHRs) to support complex clinical decision-making and precision medicine.

• The demand for scalable AI infrastructure, high-performance computing, secure management of healthcare data, and seamless integration with EHR, PACS, laboratory information systems (LIS), and healthcare analytics platforms highlighted cloud deployment as a primary focus in 2025.

• Transformer-based architectures played a significant role in the technology component of 2025 by providing high accuracy and scalability for large language models (LLMs), multimodal AI, clinical decision support, medical imaging analysis, drug discovery, and biomedical research.

• In 2025, North America is expected to be the top region in the global Medical Foundation Models market, as it has many major AI technology providers, life sciences firms, and healthcare organizations, and higher investments in precision medicine, excellent healthcare systems, and higher adoption of generative AI.

Significant Growth Factors

The adoption of multimodal AI models is becoming ubiquitous in different clinical decision-making and healthcare workflows.

The application of multimodal AI models in clinical decision support and across the healthcare workflows is gaining momentum. The medical foundation models are being adopted across different sectors, including healthcare, pharmaceuticals, and research, for clinical decisions, medical imaging analysis, medical documentation, disease diagnosis, personalized patient care, and other applications. 

It can process large volumes of healthcare data, including clinical text, medical images, pathology slides, laboratory reports, genomic data, and electronic health records (EHRs), allowing for the accurate interpretation of the clinical information and the automation of complex healthcare processes. Healthcare organizations are turning to medical foundation models at a faster pace, with investments in generative AI and precision medicine technologies. Increasingly connected with health care data systems and AI-driven drug discovery.

Integration with healthcare data platforms is growing, and so is drug discovery using AI.

The medical foundation models market is expected to generate significant opportunities due to the increasing investments in healthcare digital transformation, cloud computing, and biomedical AI infrastructure. Medical foundation models are progressively becoming interwoven with electronic health records (EHRs), laboratory information systems (LIS), picture archiving and communication systems (PACS), genomic databases, and knowledge graphs for healthcare.

Medical foundation models are now being integrated into electronic health records (EHRs), laboratory information systems (LIS), picture archiving and communication systems (PACS), genomic databases, and healthcare knowledge graphs, enabling intelligent clinical reasoning and AI integration across the enterprise.

Pharmaceutical and biotechnology firms are also using these models to expedite drug discovery, biomarker identification, clinical trial optimization and real-world evidence analysis. In the era of continuous innovation, the contribution of medical foundation models to the future of healthcare technology grows stronger through the steady progress of multimodal AI, large language models (LLMs), retrieval-augmented generation (RAG), and federated learning.

Driver Impact Analysis

Restraints Impact Analysis

What are the Major Advances Changing the Medical Foundation Models market Today

The integration of Large Language Models (LLM) and Multimodal AI in Clinical Decision Intelligence.

Medical foundation models are changing healthcare through the use of large language models (LLMs), multimodal AI, and transformer architectures, which analyze medical data and interpret it across a variety of modalities, such as electronic health records (EHRs), medical images, pathology slides, genomics, laboratory reports, and clinical notes. Such models offer high-level clinical decision-making support, support medical documentation, create patient summaries, and support diagnosis and therapy planning. They can handle complex biomedical knowledge and are successfully incorporating multiple types of data to improve diagnostic accuracy, productivity of the clinician, and personalized care for the patient.

The Foundation Models are designed to drive drug discovery, clinical research, and precision medicine.

The fast development of foundation models is revolutionizing pharmaceutical research and precision medicine with enhanced capabilities to identify drug targets, discover biomarkers, predict molecular properties, and optimize clinical trials. The biomedical literature, genomic databases, proteomics data, real-world evidence (RWE), and clinical datasets are analyzed using AI-powered foundation models to observe and uncover novel therapeutic insights and support personalized treatment strategies. Pharma, biotechnology, and research institutes are picking up the pace in adopting it, which is decreasing the time to market for drugs, increasing research efficiency, and propelling innovation in the life sciences.

Cloud-based AI infrastructure and federated learning that enables scalable healthcare AI.

Medical foundation models can be securely deployed in hospitals, health care networks, and research organizations thanks to the emergence of cloud-native AI platforms, federated learning, and privacy-preserving AI. The modern platforms enable large-scale model training, continuous learning, real-time inference, and integration with other hospital and electronic health records systems (EHRs, PACS, laboratory information systems (LIS), and hospital information systems (HIS)).

Federated learning allows for development of a model without sharing sensitive patient information, with cloud infrastructure providing flexibility in scalability, interoperability, regulatory compliance, and enterprise-wide AI deployment. These developments are driving digital transformation, enhancing clinical processes, and driving the use of trustworthy and reliable AI in healthcare globally.

Category Wise Insights

By Model Type

What Makes Multimodal Foundation Models so Popular?

In 2025, the global Medical Foundation Models market was dominated by the Multimodal Foundation Models segment because it handles and analyses various types of medical data, such as clinical text, medical images, pathology slides, laboratory reports, genomic data, and electronic health records (EHRs). These models can be used for detailed clinical reasoning, better diagnostics, precision medicine, and better decision-making through the healthcare workflows. The hospital, pharmaceutical, and research sectors continue to drive the use of multimodal AI, further solidifying its position of leadership.

By Deployment Mode

So why is Cloud Deployment leading the market?

The Cloud segment accounted for the largest market share in the global Medical Foundation Models market in 2025, primarily due to the growing demand for scalable AI infrastructure, high-performance computing, and secure healthcare data management. Cloud platforms allow healthcare organizations to efficiently train, deploy and manage foundation models and to integrate with EHRs, PACS, laboratory information systems (LIS), genomic databases and health care analytics platforms. Adopting the cloud continues to gain momentum in healthcare ecosystems due to its lower infrastructure costs, its ability to scale quickly, and enterprise-wide AI deployment.

By Technology

Why Transformer-based Architectures Dominate the Market?

Transformer-based architectures were the top technology segment in 2025, as they are the backbone of large language models (LLMs), multimodal AI, and other medical foundation models. Their knowledge of long clinical contexts, processing various types of healthcare data, and predictive accuracy have made them the preferred architecture for clinical decision support, medical imaging analysis, biomedical research, drug discovery, and all aspects of the healthcare sector. The transformer market in the healthcare and life sciences industry is further gaining momentum due to ongoing updates in its efficiency, scalability, and domain-specific optimization.

Report Scope

Regional Analysis

How Big is the North America Market Size?

The North America Medical Foundation Models market size is forecast to reach USD 1.77 billion by 2025 and is expected to reach around USD 3.44 billion by 2035 with a CAGR of 6.84% from 2026 to 2035.

Why Did North America Dominate the Market in 2025?

North America's high number of hospitals, pharmaceutical, biotechnology, and research institutions in the region with extensive use of generative AI across these sectors and the advanced healthcare infrastructure and AI ecosystem made North America contribute around 44.8% to the global Medical Foundation Models market in 2025.

Key Market Players

• Microsoft Corporation

• Google LLC (Google DeepMind & Google Cloud)

• Amazon Web Services (AWS)

• NVIDIA Corporation

• OpenAI

• Oracle Health (Oracle Corporation)

• IBM Corporation (Watsonx Health)

• GE HealthCare Technologies Inc.

• Siemens Healthineers AG

• Tempus AI Inc.

• Aidoc Medical Ltd.

• PathAI Inc.

• Owkin Inc.

• Insilico Medicine

• Hippocratic AI

• Others

Key Developments

Market Trends Have Seen Extensive Evolution As bio-isobutanol developers have moved to commercialize and diversify their product offerings, they have faced significant evolution in global markets for their bio-isobutanol derivatives within fuel, coatings, and paints markets.

• June 2025 – Microsoft bolstered its healthcare artificial intelligence capabilities with new Medical Foundation Models on Azure AI that can enable multimodal clinical reasoning, automate medical documentation, and integrate with electronic health records (EHR), medical imaging systems, and healthcare workflows.

• In April 2025, Google Cloud announced the availability of Medical Foundation Models, which expand the capabilities of its foundation models for generative AI in healthcare to enhance diagnostic accuracy, clinician productivity, and patient care in clinical documentation, medical imaging analysis, biomedical research, and precision medicine.